You Might Like
Haffkine's rollout of Covaxin not likely till end of this yearIndiaTimes - Published | |
Mixing Covishield & Covaxin gives better immunity: ICMRIndiaTimes - Published | |
Qatar sets ‘immunity validity period’: 9 months for Covishield & 6 months for Covaxin last shotIndiaTimes - Published | |
USFDA paves way for Covaxin trials in USIndiaTimes - Published | |
USFDA lifts clinical hold on Ocugen's IND application for Covaxin paving way for its evaluation for US marketIndiaTimes - Published | |
Covaxin granted Emergency Use Listing in 13 nations as on Jan 31 according to WHO: GovtCovaxin has been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO, Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday...IndiaTimes - Published | |
From free recharge for COVID vaccine to Neeraj Chopra's pro-farmer tweet: Top 'Fake News' stories of 2021The biggest fake news stories that fooled people included claims of cow serum in Covaxin, outrageous RBI scheme and the annual false Ratan Tata quote.DNA - Published | |
Covaxin showed better antibody response in 2-18 year olds than adults: Bharat BiotechIndiaTimes - Published | |
States prepare to vaccinate teenagers in age group of 15-18 years from January 3Registration on CoWIN portal will begin from January 1 and on-site registrations will start from January 3. Only Covaxin will be used for vaccination.DNA - Published | |
'Precautionary dose' for 60+ with comorbidities 9 months after 2nd dose - Check new guidelinesBharat Biotech's Covaxin has been granted approval for restricted use in an emergency situation in the age group between 12 and 18 years.DNA - Published | |
Covid vaccination: Children between 15-18 years can register on CoWin from Jan 1, on-site from Jan 3Children between 15 and 18 years can register online on CoWin from January 1 or onsite at vaccination centres to receive Covaxin shots from January 3. They can register themselves online through an..IndiaTimes - Published | |
Covaxin only vaccine option for children in 15-18 years age group: GovtIndiaTimes - Published | |
Covaxin has shown good immune response in children during trials, says NTAGI chiefIndiaTimes - Published | For now, Covaxin likely to be only Covid vaccine available for children of 15-18 yearsIndiaTimes - Published |
Govt's decision on Covid vaccination for children 'unscientific': Senior AIIMS epidemiologistA senior epidemiologist at AIIMS who is the principal investigator of Covaxin trials for adults and children at the institute termed the Centre's decision to vaccinate children against Covid..IndiaTimes - Published | MNCs tried to scuttle WHO nod for Covaxin: CJI RamanaChief Justice of India NV Ramana on Thursday lamented that attempts were made to prevent the indigenously developed Covaxin from getting WHO recognition. “Several multi-national companies, like..IndiaTimes - Published |
Covid-19: Vaccine for 15-18-year-olds, ‘precaution dose’ for health workers, 60+ with ailmentsPM Narendra Modi announced on Saturday that “precaution doses” (boosters) of Covid vaccines for health and frontline workers as well as for those above 60 with co-morbidities will begin from..IndiaTimes - Published | Covaxin gets DCGI nod for emergency use for kids aged 12-18 yearsIndigenously developed Covid-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use in children aged between 12-18 years. The drug regulator’s..IndiaTimes - Published |
DCGI nod to Covaxin for use in children above 12 years with certain conditionsIndiaTimes - Published | Bharat Biotech seeks DCGI nod for phase-3 study of intra-nasal Covid vaccine as booster dose"Bharat Biotech has put in an application seeking permission to conduct a study titled 'A Phase 3 Study to Evaluate the Safety and Immunogenicity of BBV154 and BBV152 as third dose (booster) to..IndiaTimes - Published |
Covishield production capacity 250-275 million doses a month, Covaxin 50-60 million: GovtIndiaTimes - Published | 10 months on, chief secretary of Maharashtra takes his first shotAlmost 10 months after Covid vaccination for frontline staff started, Maharashtra’s senior-most bureaucrat, acting chief secretary Debashish Chakrabarty, 59, took his first shot on Thursday at JJ..IndiaTimes - Published |
Can Covishield, Covaxin provide protection against Omicron variant? Here's what experts are sayingAs the Omicron variant spreads to multiple countries, people are wondering if Indian vaccines will be effective against the new COVID-19 variant.DNA - Published | Expert: Covishield, Covaxin may offer protection against OmicronIndiaTimes - Published |
India willing to supply Covishield, Covaxin: Mandaviya to Latin American, Caribbean envoysInteracting with ambassadors of Latin American and Caribbean nations, Union Health Minister Mansukh Mandaviya on Thursday said India is willing to supply Covishield and Covaxin to these countries...IndiaTimes - Published | Lancet Infectious Diseases study compare well with phase 3 clinical trials of Covaxin: Bharat BiotechCommenting on the study of the Lancet Infectious Diseases on the effectiveness of Covaxin (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well..IndiaTimes - Published |
India’s Covaxin gave lower protection in Delta waveTwo doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India's indigenous coronavirus vaccine published in The Lancet Infectious..IndiaTimes - Published | Covaxin shows 50% effectiveness against symptomatic Covid-19 in real-world assessment: Lancet studyTwo doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India's indigenous coronavirus vaccine published in The Lancet Infectious..IndiaTimes - Published |
Canada set to recognise Covaxin from Nov 30In a big relief to travellers from India, Canada will recognise Bharat Biotech's Covaxin from November 30. It has expanded its list of WHO-approved Covid-19 vaccines that will be accepted for travel to..IndiaTimes - Published | New Zealand adds Covishield, Covaxin to approved COVID-19 vaccine listNow, travellers who got jabbed with the Covishield or Covaxin shot can enter New Zealand without a quarantine period.DNA - Published |
How monkeys were tracked for Covaxin trial!IndiaTimes - Published | Lost 10 years of life in 18 months due to Covaxin stress, says Krishna EllaIn a face-to-face interview, Ella opened up to TOI about the thrill of developing India’s first indigenous Covid-19 vaccine, but also spoke about the dangers and controversies that dogged the company..IndiaTimes - Published |
Bharat Biotech's Covaxin safe, 77.8% effective against symptomatic COVID-19: LancetThe findings published by Lancet show Covaxin has 77.8% efficacy against symptomatic COVID-19 and a 63.6% protection against asymptomatic patients.DNA - Published | Covaxin well tolerated, phase 3 data shows 77.8% efficacy against symptomatic Covid: LancetJust a week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, prestigious medical journal Lancet has stated that phase 3 data of the vaccine demonstrates 77.8%..IndiaTimes - Published |
WHO's approval to Covaxin to significantly ease travel for vaccinated Indians: MEAIndiaTimes - Published | Booster dose after 6 months of 2nd Covaxin shot ideal: Bharat Biotech CMD Krishna EllaElla’s remarks at the Times Now Summit 2021 on Wednesay will further animate the discussion on the subject, as so far, the government and some experts are of the view that a booster dose is not..IndiaTimes - Published |
UK to add Bharat Biotech's Covaxin to approved vaccine list from November 22The UK will be approving Bharat Biotech's Covaxin for its updated vaccine list for international travelers from November 22.DNA - Published | Covid-19: Govt to start vaccination for kids only after nod to CovaxinChildren may have to wait for some more time to get vaccinated against Covid-19 as the government will start immunisation for kids only after Bharat Biotech's Covaxin is approved for use which might..IndiaTimes - Published |
UK to recognise Covaxin from Nov 22; US welcomes inclusion of Bharat Biotech vaccine in WHO-approved listThe UK has said it will recognise made-in-India Covaxin starting November 22, while the US Centers for Disease Control and Prevention (CDC) on Monday described the World Health Organization’s..IndiaTimes - Published | Bharat Biotech's US partner Ocugen seeks Covaxin approval for childrenCovaxin uses the same Vero Cell manufacturing platform as other childhood vaccines, including the inactivated polio vaccine.DNA - Published |
Bharat Biotech's US partner Ocugen files EUA request with FDA for paediatric use of CovaxinIndiaTimes - Published | Covid-19 vaccination: 'No shortage for door-to-door drive'Ahead of the proposed door to door vaccination drive by the centre, national task force members have ruled out any shortage of vaccines for the drive with nearly 30 crore vaccines to be procured from..IndiaTimes - Published |
Travellers vaccinated with Bharat Biotech's Covaxin can now enter USCovaxin developed by Hyderabad-based Bharat Biotech in partnership with the Indian Council of Medical Research has a 78% efficacy rate against COVID.DNA - Published Also reported by •IndiaTimes | How WHO nod for Bharat Biotech's Covaxin will benefit Indians - Know hereWHO has approved Bharat Biotech's Covaxin for emergency use listing yesterday, and this move can be beneficial for many Indians.DNA - Published |
PM pushed for Covaxin nod at G20 meet with WHO chiefIndiaTimes - Published | In Diwali gift for Indians, WHO grants emergency use licence to CovaxinAfter a long wait, the World Health Organisation (WHO) on Wednesday gave a Diwali gift to millions of vaccinated Indians by finally granting emergency use listing (EUL) to Covaxin. The nod has been..IndiaTimes - Published |
India's Covaxin gets WHO approval: Who said whatIndiaTimes - Published | Covaxin 'extremely suitable' for low, middle-income countries due to easy storage requirements: WHOIndiaTimes - Published |
Jaishankar welcomes WHO's decision to grant Emergency Use Listing to CovaxinIndiaTimes - Published | Bharat Biotech gets DCGI nod for shelf-life extension of its COVID-19 vaccine CovaxinBharat Biotech had submitted its data to the drug regulator and sought a shelf-life extension for its vaccine.DNA - Published |
